2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Non-Proliferative Diabetic Retinopathy: new trials by email Literature Review of Non-Proliferative Diabetic Retinopathy trials Research Report on Non-Proliferative Diabetic Retinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR B55R1 and B55R2, B55R1 and placebo for B55R2 - Non-Proliferative Diabetic Retinopathy | Phase 4 | Completed | AJU Pharm Co., Ltd. | 53 | 2022-04-28 | 2026-09-04 |
| Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema Bevacizumab - Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy | Phase 4 | Completed | King Khaled Eye Specialist Hospital | 50 | 2013-06-01 | 2021-12-03 |
Bevacizumab (1)
AJU Pharm Co., Ltd. (1) · King Khaled Eye Specialist Hospital (1)
Saudi Arabia (1) · South Korea (1)